Immune Disorder (excluding AIDS and malignancy) - Miscellaneous
NCT01503515
Clinical Trial Information
Trial Number: NCT01503515 (ClinicalTrials.gov)
Disease Type:
- Immune Disorder (excluding AIDS and malignancy) - Miscellaneous
- Miscellaneous Neoplasm - Other
Trial Title:
A Phase III Open-Label Trial of Caspofungin vs. Azole Prophylaxis for Patients at High-Risk for Invasive Fungal Infections (IFI) Following Allogeneic Hematopoietic Cell Transplantation (HCT)
Study ID:
ACCL1131
Images are available?:
No
Is this a NCI-MATCH Trial?:
No
Datasets Linked to Trial
Title | Description |
---|---|
NCT01503515-D2 | NCT01503515-D2: There are 2 datasets associated with PMID 33136159. This dataset, NCT01503515-D2, provides the information for the demographic baseline characteristics (Table 1), transplant baseline characteristics (Table 2), post-randomization factors (Table 3), cumulative incidence and other outcomes (Table 4 & Figure 2) and organisms causing the invasive fungal disease (Table 5). There is one row per patient. NCT01503515-D1 contains the data reported in the CONSORT diagram in the manuscript (Figure 1). |
NCT01503515-D1 | NCT01503515-D1: There are 2 datasets associated with PMID 33136159. This dataset, NCT01503515-D1, provides the information for the CONSORT diagram in the manuscript (Figure 1). Data provided for all enrolled patients (N=292). There is one row per patient. NCT01503515-D2 contains data on baseline characteristics, post-randomization factors, cumulative incidence, and organism details. |
Accessibility | Disclaimer | FOIA | HHS Vulnerability Disclosure | Privacy & Security
U.S. Department of Health and Human Services | National Institutes of Health | National Cancer Institute | USA.gov
NIH…Turning Discovery Into Health®